[VRDN] QoQ Quarter Result on 31-Dec-2016 [#Q4]

Stock
[VRDN] Viridian Therapeutics, Inc.
Announcement Date
24-Mar-2017
Financial Year
2016
Quarter
31-Dec-2016 [#Q4]
Profit Trend
QoQ- -202.88%
YoY- -86.91%
Quarter Report
VRDN's Result
VRDN's Financial Summary
View:
Show?
Quarter Result
30/09/17 30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 CAGR
Revenue 1,631 718 462 756 889 874 818 58.35%
PBT -5,834 -7,312 -6,980 -5,570 -1,839 -2,507 -2,758 64.70%
Tax 113 102 30 -71 0 0 0 -
NP -5,834 -7,312 -6,980 -5,570 -1,839 -2,507 -2,758 64.70%
Tax Rate - - - - - - - -
Total Cost 7,465 8,030 7,442 6,326 2,728 3,381 3,576 63.26%
Ratio Analysis
30/09/17 30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 CAGR
NP Margin -357.69 -1,018.38 -1,510.82 -736.77 -206.86 -286.84 -337.16 4.01%
Per Share
30/09/17 30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 CAGR
EPS -4.06 -5.12 -9.06 -7.23 -2.56 -3.50 -3.85 3.60%
EPS Diluted -4.06 -5.12 -9.06 -7.23 -2.56 -3.50 -3.85 3.60%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.